Mono Pharmacare Ltd
Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]
- Market Cap ₹ 35.3 Cr.
- Current Price ₹ 20.0
- High / Low ₹ 38.0 / 19.0
- Stock P/E 11.4
- Book Value ₹ 17.7
- Dividend Yield 0.00 %
- ROCE 10.4 %
- ROE 10.4 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.13 times its book value
- Debtor days have improved from 128 to 83.5 days.
- Company's working capital requirements have reduced from 224 days to 148 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.2.54 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 13.92 | 70.72 | 82.64 | |
| 13.05 | 68.27 | 80.08 | |
| Operating Profit | 0.87 | 2.45 | 2.56 |
| OPM % | 6.25% | 3.46% | 3.10% |
| 0.20 | 1.70 | 2.54 | |
| Interest | 0.38 | 1.21 | 1.24 |
| Depreciation | 0.02 | 0.08 | 0.08 |
| Profit before tax | 0.67 | 2.86 | 3.78 |
| Tax % | 19.40% | 14.69% | 18.25% |
| 0.54 | 2.44 | 3.09 | |
| EPS in Rs | 0.44 | 1.38 | 1.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 12.37 | 17.67 | 17.67 |
| Reserves | 1.03 | 10.44 | 13.53 |
| 12.51 | 13.27 | 23.69 | |
| 3.15 | 4.02 | 11.18 | |
| Total Liabilities | 29.06 | 45.40 | 66.07 |
| 0.19 | 0.14 | 0.22 | |
| CWIP | 0.00 | 0.00 | 0.02 |
| Investments | 1.97 | 3.59 | 10.84 |
| 26.90 | 41.67 | 54.99 | |
| Total Assets | 29.06 | 45.40 | 66.07 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -13.49 | -10.32 | -0.73 | |
| -2.18 | -1.66 | -7.43 | |
| 15.90 | 12.00 | 8.02 | |
| Net Cash Flow | 0.23 | 0.02 | -0.14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 211.87 | 90.01 | 83.48 |
| Inventory Days | 466.39 | 118.95 | 136.54 |
| Days Payable | 64.21 | 16.55 | 45.79 |
| Cash Conversion Cycle | 614.04 | 192.41 | 174.22 |
| Working Capital Days | 377.06 | 146.94 | 148.36 |
| ROCE % | 12.10% | 10.43% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
13 October 2025 - RTA confirms Reg.74(5) not applicable for quarter ended Sep 30, 2025; all shares in demat.
-
Shareholders meeting
1 October 2025 - Only digital signatures and timestamps; no announcement content.
-
Shareholders meeting
29 September 2025 - Mono Pharmacare Limited has informed regarding Proceedings of undefined held on September 29, 2025
-
Trading Window
27 September 2025 - Trading window closed from 1 Oct 2025 until 48 hours after H1 results for Sep 30, 2025.
-
Record Date
9 September 2025 - Record date set as 24 Sep 2025 for remote e-voting for AGM on 29 Sep 2025.
Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.